benfovir AG is a pharmaceutical company based in Darmstadt in Hesse that specializes in the therapy of viral infections such as the SARS-CoV-2 virus. At this stage, one compound is under clinical development. This compound inhibits the sugar metabolism in infected cells by disabling the formation of the crucial building blocks for virus production (ribose-5-phosphate and acetyl-CoA), and at the same time by preventing the overshooting of the immune system.
Company Details
- Employees
- 7
- Founded
- 2020
- Address
- Gräfenhäuserstrasse 26, Darmstadt,hesse 64293,germany
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://benfovir.com/
- Keywords
- Wiesbaden.
- HQ
- Darmstadt, Hesse
Benfovir Ag Questions
Benfovir Ag's website is https://benfovir.com/
Benfovir Ag's LinkedIn profile is https://de.linkedin.com/company/benfovir-ag
Benfovir Ag has
7 employees.
View email and phone details for 7
employees at Benfovir Ag.
Benfovir Ag's industry is
Biotechnology Research
Benfovir Ag's top competitors are
Mitodicure Gmbh,
Zyagnum Ag,
Msc Woundcare,
Vitapharm Gmbh,
Vertex Pharmaceuticals,
Belano Medical Ag,
Dr. Notghi Academy,
Absorbest,
Noggo E.v.,
Aprofol Ag.
Benfovir Ag's categories are Biotechnology Research
Benfovir Ag's founding year is 2020
